NCT04958369

Brief Summary

The implantation of cardiac electronic devices is a common procedure in the Electrophysiology Laboratory. The most commonly used venous access sites are the cephalic, the axillary and the subclavian vein. Studies comparing these options have been conducted in the past. Axillary venous access can be achieved either through axillary vein angiography or by ultrasound guidance. Nevertheless, appropriate training is required for the ultrasound-guided axillary puncture technique-as well as for the cephalic vein cutdown technique. Data from randomized trials regarding direct comparison of the two methods in terms of efficacy and safety are very limited. The purpose of the study is the comparison of the efficacy and safety of the ultrasound-guided axillary venous access technique versus the cephalic venous access using the cut-down technique in patients requiring intravenous cardiac device (single-chamber/dual-chamber pacemaker/defibrillator) implantation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 27, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 12, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2022

Completed
Last Updated

November 1, 2022

Status Verified

October 1, 2022

Enrollment Period

1.4 years

First QC Date

June 27, 2021

Last Update Submit

October 31, 2022

Conditions

Keywords

pacemakerimplantable cardioverter-defibrillatoraxillary veincephalic veinulatraound

Outcome Measures

Primary Outcomes (1)

  • Rate of successful cardiac device implantation

    Intervention time (Day 0)

Secondary Outcomes (7)

  • Duration of lead insertion procedure

    Intervention time (Day 0)

  • Total procedure duration

    Intervention time (Day 0)

  • Radiation dose

    Intervention time (Day 0)

  • Fluoroscopy time

    Intervention time (Day 0)

  • Procedure-related complication rate (pneumothorax, cardiac tamponade, pocket hematoma, lead displacement, fever, need for antibiotic treatment)

    Day 0-30

  • +2 more secondary outcomes

Study Arms (2)

Ultrasound-guided axillary venous access

ACTIVE COMPARATOR

Cardiac device implantation will be performed with ultrasound-guided axillary venous access.

Device: Ultrasound-guided axillary venous access

Cephalic venous access

ACTIVE COMPARATOR

Cardiac device implantation will be performed with conventional cephalic venous access (cut-down technique).

Device: Cephalic venous access

Interventions

Venous access is obtained through ultrasound-guided axillary vein puncture and Seldinger technique.

Ultrasound-guided axillary venous access

Venous access is obtained through cephalic vein cut-down.

Cephalic venous access

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Indication for single- or dual-chamber pacemaker of defibrillator implantation
  • Written informed consent

You may not qualify if:

  • Indication for biventricular pacemaker/defibrillator
  • Upgrade in pacing or defibrillation system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Patras

Pátrai, Rion, 26504, Greece

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Cardiologist

Study Record Dates

First Submitted

June 27, 2021

First Posted

July 12, 2021

Study Start

May 1, 2021

Primary Completion

September 30, 2022

Study Completion

October 30, 2022

Last Updated

November 1, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations